| |
Anti-malarial type
|
|---|
| |
AS+SP (n = 382)
|
SP or Chloroquine (n = 122)
|
Quinine (n = 39)
|
Artemether (n = 296)
|
Other†(n = 36)
|
|---|
|
Overall
|
43.9 (39.6-48.2)
|
13.4 (10.6-16.2)
|
4.5 (2.8-6.1)
|
33.7 (30.0-37.4)
|
4.6(2.7-6.5)
|
|
By treatment source
| | | | | |
|
Government
| | | | | |
|
Hospital
|
29.0 (21.2-36.8)
|
20.3 (11.3-29.3)
|
50.2 (27.8-72.6)
|
28.4 (21.4-35.3)
|
21.4 (7.6-35.1)
|
|
Health centre
|
36.5 (27.3-45.7)
|
24.0 (14.7-33.2)
|
33.6 (11.1-56.1)
|
35.8 (29.2-42.4)
|
20.2 (4.7-35.8)
|
|
Basic health unit
|
10.5 (4.9-16.0)
|
14.6 (6.6-22.7)
|
5.4 (-0.0-11.1)
|
13.7 (7.6-19.7)
| |
|
Community Health Worker
|
7.0 (2.1-11.8)
|
5.8 (0.7-11.0)
|
7.2 (-0.2-14.6)
|
4.4 (1.7-7.2)
|
5.5 (-5.0-15.9)
|
|
Private
| | | | | |
|
Health facility/pharmacy/drug Store
|
14.6 (9.3-20.0)
|
20.0 (10.9-29.1)
|
2.1 (-1.9-6.2)
|
14.7 (10.3-19.1)
|
40.2 (18.3-62.1)
|
|
Shop
|
1.6 (0.3-28.6)
|
15.2 (7.3-23.2)
|
1.4 (-1.4-4.2)
|
1.1 (-0.6-2.9)
|
12.7 (-4.3-29.9)
|
|
Other
|
0.7 (-0.0-1.7)
| | |
1.8 (-0.0-3.8)
| |
- Proportions are weighted and cluster adjusted.
- †13 individuals took AL, 23 took unspecified anti-malarial drugs;
